These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 24612251)

  • 41. Natural history and disease progression in Chinese chronic hepatitis B patients in immune-tolerant phase.
    Hui CK; Leung N; Yuen ST; Zhang HY; Leung KW; Lu L; Cheung SK; Wong WM; Lau GK;
    Hepatology; 2007 Aug; 46(2):395-401. PubMed ID: 17628874
    [TBL] [Abstract][Full Text] [Related]  

  • 42. How can we enhance the performance of liver stiffness measurement using FibroScan in diagnosing liver cirrhosis in patients with chronic hepatitis B?
    Kim SU; Kim DY; Park JY; Lee JH; Ahn SH; Kim JK; Paik YH; Lee KS; Chon CY; Choi EH; Song KJ; Park YN; Han KH
    J Clin Gastroenterol; 2010 Jan; 44(1):66-71. PubMed ID: 19609218
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Assessment of fibrosis by transient elastography compared with liver biopsy and morphometry in chronic liver diseases.
    Wong GL; Wong VW; Choi PC; Chan AW; Chum RH; Chan HK; Lau KK; Chim AM; Yiu KK; Chan FK; Sung JJ; Chan HL
    Clin Gastroenterol Hepatol; 2008 Sep; 6(9):1027-35. PubMed ID: 18456573
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Commentary: coincidental metabolic syndrome increases the risk of liver fibrosis progression in patients with chronic hepatitis B - authors' reply.
    Wong GL; Wong VW
    Aliment Pharmacol Ther; 2014 May; 39(10):1236-7. PubMed ID: 24735138
    [No Abstract]   [Full Text] [Related]  

  • 45. Dual cut-off transient elastography to assess liver fibrosis in chronic hepatitis B: a cohort study with internal validation.
    Viganò M; Paggi S; Lampertico P; Fraquelli M; Massironi S; Ronchi G; Rigamonti C; Conte D; Colombo M
    Aliment Pharmacol Ther; 2011 Aug; 34(3):353-62. PubMed ID: 21631559
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Optimal time for restoring the reliability of liver stiffness measurement in patients with chronic hepatitis B experiencing acute exacerbation.
    Park H; Kim SU; Kim D; Kim DY; Ahn SH; Han KH; Chon CY; Park JY
    J Clin Gastroenterol; 2012 Aug; 46(7):602-7. PubMed ID: 22772739
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Transient elastography, APRI, and ultrasound have minimal utility in chronic low-replicative hepatitis B infection.
    Assal A; Mackie D; Cooper CL
    Eur J Gastroenterol Hepatol; 2014 Sep; 26(9):1010-4. PubMed ID: 25051218
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Chronic inflammation involves CCL11 and IL-13 to facilitate the development of liver cirrhosis and fibrosis in chronic hepatitis B virus infection.
    Wong SW; Ting YW; Yong YK; Tan HY; Barathan M; Riazalhosseini B; Bee CJ; Tee KK; Larsson M; Velu V; Shankar EM; Mohamed R
    Scand J Clin Lab Invest; 2021 Apr; 81(2):147-159. PubMed ID: 33528280
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation of transient elastography for fibrosis assessment compared with large biopsies in chronic hepatitis B and C.
    Verveer C; Zondervan PE; ten Kate FJ; Hansen BE; Janssen HL; de Knegt RJ
    Liver Int; 2012 Apr; 32(4):622-8. PubMed ID: 22098684
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mutations in basal core promoter is associated with significant fibrosis in both HBeAg positive and negative treatment-naïve chronic hepatitis B.
    Yan LB; Zhu X; Bai L; Tang XQ; Du LY; Chen EQ; Liang LB; Tang H
    Clin Res Hepatol Gastroenterol; 2017 Jun; 41(3):296-302. PubMed ID: 27988305
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Interpretation of liver stiffness measurement-based approach for the monitoring of hepatitis B patients with antiviral therapy: A 2-year prospective study.
    Liang X; Xie Q; Tan D; Ning Q; Niu J; Bai X; Chen S; Cheng J; Yu Y; Wang H; Xu M; Shi G; Wan M; Chen X; Tang H; Sheng J; Dou X; Shi J; Ren H; Wang M; Zhang H; Gao Z; Chen C; Ma H; Chen Y; Fan R; Sun J; Jia J; Hou J
    J Viral Hepat; 2018 Mar; 25(3):296-305. PubMed ID: 29080299
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Successful therapy with tenofovir disoproxil fumarate (TDF) in patients with chronic hepatitis B (CHB) does not guarantee amelioration of liver damage assessing by transient elastography. A retrospective - prospective multicenter study.
    Kranidioti H; Zisimopoulos K; Oikonomou T; Voulgaris T; Siakavellas S; Agorastou P; Deutsch M; Triantos C; Goulis I; Papatheodoridis G; Manolakopoulos S
    BMC Gastroenterol; 2024 Apr; 24(1):133. PubMed ID: 38609880
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hepatitis B e antigen-positive and high levels of alanine aminotransferase are associated with prevalence of metabolic syndrome in chronic HBV patients.
    Ha M; Xia W; Tang D; Wu J; Sun L; Shen W; Huang Z; Chen X; Shan W
    Obes Res Clin Pract; 2016; 10(6):673-679. PubMed ID: 26515918
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hepatic Inflammation May Influence Liver Stiffness Measurements by Transient Elastography in Children and Young Adults.
    Raizner A; Shillingford N; Mitchell PD; Harney S; Raza R; Serino J; Jonas MM; Lee CK
    J Pediatr Gastroenterol Nutr; 2017 Apr; 64(4):512-517. PubMed ID: 27540711
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Associated Factors for Metabolic Syndrome in the Older Adults with Chronic Virus Hepatitis in the Community.
    Kuo YH; Tsai MC; Kee KM; Chang KC; Wang JH; Lin CY; Lin SC; Lu SN
    PLoS One; 2016; 11(5):e0155544. PubMed ID: 27177024
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of Concurrent Metabolic Dysfunction-Associated Steatotic Liver Disease on Serial Non-invasive Fibrosis Markers in Chronic Hepatitis B.
    Con D; Tu S; Clayton-Chubb D; Lubel JS; Nicoll AJ; Sawhney R; Bloom S
    Dig Dis Sci; 2024 Apr; 69(4):1496-1506. PubMed ID: 38376788
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Accuracy of FibroScan for the diagnosis of liver fibrosis influenced by serum alanine aminotransferase levels in patients with chronic hepatitis B].
    Chen XB; Zhu X; Chen LY; Chen EQ; Tang H
    Zhonghua Gan Zang Bing Za Zhi; 2011 Apr; 19(4):286-90. PubMed ID: 21586228
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Liver fibrosis progression in patients with chronic hepatitis B: a prospective study with paired transient elastography.
    Wong VW; Chan HL; Wong GL
    Hong Kong Med J; 2017 Aug; 23 Suppl 5(4):23-26. PubMed ID: 28943521
    [No Abstract]   [Full Text] [Related]  

  • 59. Sustained virological response halts fibrosis progression: A long-term follow-up study of people with chronic hepatitis C infection.
    Chen Yi Mei SLG; Thompson AJ; Christensen B; Cunningham G; McDonald L; Bell S; Iser D; Nguyen T; Desmond PV
    PLoS One; 2017; 12(10):e0185609. PubMed ID: 29065124
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Serum hepatitis B surface antigen levels help predict disease progression in patients with low hepatitis B virus loads.
    Tseng TC; Liu CJ; Yang HC; Su TH; Wang CC; Chen CL; Hsu CA; Kuo SF; Liu CH; Chen PJ; Chen DS; Kao JH
    Hepatology; 2013 Feb; 57(2):441-50. PubMed ID: 22941922
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.